Journey Medical (DERM) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:46:51.783Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:46:51.783Z.

Quote observation: 2026-10-06T19:44:28.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 6.225
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.2259

FMP input reference: 0892caefd8f82b9b6348fc9a5fa5a469bdb14ad1115ffcc50d65bebd568510ae

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

DERM PE Ratio Metrics

PE RATIO

N/A

DERM Competitors' PE Ratio

DERM

Journey Medical Corporation

Current

Market Cap

$171.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DTIL

Precision BioSciences, Inc.

vs DERM

Market Cap

$170.69M

PE Ratio

N/A

TTM Avg

11.57

3Y Avg

11.57

5Y Avg

11.57

ORGO

Organogenesis Holdings Inc.

vs DERM

Market Cap

$169.45M

PE Ratio

N/A

TTM Avg

22.05

3Y Avg

43.38

5Y Avg

28.58

MDWD

MediWound Ltd.

vs DERM

Market Cap

$168.79M

PE Ratio

N/A

TTM Avg

7.76

3Y Avg

7.76

5Y Avg

7.76

PRQR

ProQR Therapeutics N.V.

vs DERM

Market Cap

$173.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUE

Cue Biopharma, Inc.

vs DERM

Market Cap

$167.81M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

YARW

Yarrow Bioscience Inc

vs DERM

Market Cap

$175.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPRX

OptimizeRx Corp.

vs DERM

Market Cap

$165.68M

PE Ratio

37.80

TTM Avg

23.37

3Y Avg

23.37

5Y Avg

443.72

NKTX

Nkarta, Inc.

vs DERM

Market Cap

$165.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORMP

Oramed Pharmaceuticals Inc.

vs DERM

Market Cap

$179.46M

PE Ratio

1.07

TTM Avg

2.35

3Y Avg

8.36

5Y Avg

8.36

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Journey Medical Corporation (DERM)	$171.32M	N/A	N/A	N/A	N/A
Precision BioSciences, Inc. (DTIL)vs ›	$170.69M	N/A	11.57	11.57	11.57
Organogenesis Holdings Inc. (ORGO)vs ›	$169.45M	N/A	22.05	43.38	28.58
MediWound Ltd. (MDWD)vs ›	$168.79M	N/A	7.76	7.76	7.76
ProQR Therapeutics N.V. (PRQR)vs ›	$173.23M	N/A	N/A	N/A	N/A
Cue Biopharma, Inc. (CUE)vs ›	$167.81M	N/A	N/A	N/A	N/A
Yarrow Bioscience Inc (YARW)vs ›	$175.90M	N/A	N/A	N/A	N/A
OptimizeRx Corp. (OPRX)vs ›	$165.68M	37.80	23.37	23.37	443.72
Nkarta, Inc. (NKTX)vs ›	$165.44M	N/A	N/A	N/A	N/A
Oramed Pharmaceuticals Inc. (ORMP)vs ›	$179.46M	1.07	2.35	8.36	8.36

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$6.22

÷

Forward EPS (Est.)

$-0.04

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

DERM PE Ratio Metrics

DERM Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics